Skip to main content
logo
Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.170
0.00 (-0.01%)
Sep 8, 2026, 12:42 PM EDT - Market open

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Developing Curative Therapeutics for Patients
25.21M52.30M44.76M17.20M243.00K
Total
25.21M52.30M44.76M17.20M243.00K

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
United States
25.21M52.30M44.76M17.20M243.00K
Total
25.21M52.30M44.76M17.20M243.00K